ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 82 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 1.9%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $636,333 | -19.2% | 212,111 | +0.8% | 0.00% | – |
| Q2 2023 | $787,383 | +8.4% | 210,530 | -2.9% | 0.00% | – |
| Q1 2023 | $726,193 | +2.1% | 216,774 | +46.5% | 0.00% | – |
| Q4 2022 | $711,538 | +7.2% | 147,929 | +26.8% | 0.00% | – |
| Q3 2022 | $664,000 | -22.8% | 116,640 | -3.7% | 0.00% | – |
| Q2 2022 | $860,000 | +13.5% | 121,132 | +15.3% | 0.00% | – |
| Q1 2022 | $758,000 | +155.2% | 105,018 | +215.4% | 0.00% | – |
| Q4 2021 | $297,000 | -97.3% | 33,293 | -89.5% | 0.00% | -100.0% |
| Q3 2021 | $11,134,000 | +2279.1% | 317,579 | +1356.9% | 0.00% | – |
| Q2 2021 | $468,000 | -11.2% | 21,798 | +155.2% | 0.00% | – |
| Q1 2021 | $527,000 | – | 8,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |